Fintel reports that on November 25, 2024, TD Cowen downgraded their outlook for Despegar.com (NYSE:DESP) from Buy to Sell.

Fintel reports that on November 25, 2024, TD Cowen initiated coverage of Viridian Therapeutics (NasdaqCM:VRDN) with a Buy ...

TD Cowen analyst Derrick Wood maintained a Buy rating on Microsoft (MSFT – Research Report) today and set a price target of $475.00. The ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

As reported by the Globe and Mail, TD analyst David Kwan November 22 launched coverage of VHI with a “Buy” rating and a ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

TD Cowen's bullish report explains MicroStrategy's strategic shift to Bitcoin, foreseeing its rise as a superior store of value. Investment banking company, TD Cowen, published a recent report on ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

As previously reported, TD Cowen analyst Mario Mendonca upgraded Scotiabank (BNS) to Buy from Hold with an C$80 price target The firm, which believes ROE is “among the most important financial ...